Effect of high-dose methotrexate chemotherapy on intestinal Bifidobacteria, Lactobacillus and Escherichia coli in children with acute lymphoblastic leukemia

Experimental Biology and Medicine

Volumn 237, Issue 3, 2012, Pages 305-311

  Huang, Yongkun ^a   Yang, Wu ^a   Liu, Hua ^a   Duan, Jing ^a   Zhang, Ying ^a   Liu, Mei ^a   Li, Hailin ^a   Hou, Zongliu ^a   Wu, Kenneth K ^b,c  

^a KUNMING MEDICAL UNIVERSITY   (China)

^b MERCK RESEARCH LABORATORIES   (United States)

^c KY88 Inc   (United States)

Author keywords

Acute lymphoblastic leukemia; Bifidobacteria; Dysbacteriosis; Escherichia coli; High dose methotrexate; Intestinal flora; Lactobacillus

Indexed keywords

BACTERIAL DNA; METHOTREXATE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; BACTERIAL INFECTION; BIFIDOBACTERIACEAE; CANCER CHEMOTHERAPY; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DIGESTIVE SYSTEM DISEASE; DRUG MEGADOSE; ESCHERICHIA COLI; FECES ANALYSIS; FEMALE; HUMAN; INTESTINAL DYSBACTERIOSIS; INTESTINE FLORA; LACTOBACILLUS; MALE; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; SPECTROPHOTOMETER;

ANTIMETABOLITES, ANTINEOPLASTIC; BIFIDOBACTERIUM; CHILD; DNA, BACTERIAL; ESCHERICHIA COLI; FEMALE; HUMANS; INTESTINAL MUCOSA; LACTOBACILLUS; MALE; METHOTREXATE; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI; LACTOBACILLUS;

EID: 84863354562     PISSN: 15353702     EISSN: 15353699     Source Type: Journal    
DOI: 10.1258/ebm.2011.011297     Document Type: Article

References (40)

1. Von Stackelberg A, Hartmann R, Bührer C, Fengler R, Janka-Schaub G, Reiter A, Mann G, Schmiegelow K, Ratei R, Klingebiel T, Ritter J, Henze G, ALL-REZ BFM Study Group. High-dose compared with intermediate-dose methotrexate in children with a first relapse of acute lymphoblastic leukemia. Blood 2008;111:2573-80
2. Xu W, Tang Y, Song H, Shi S, Yang S. Retrospective study on elimination delay of methotrexate in high-dose therapy of childhood acute lymphoblastic leukemia in China. J Pediatr Hematol Oncol 2007;29:688-93
3. The Blood Set in Chapter of Pediatrics of Chinese Medical Association. Suggestion on diagnosis and treatment of children with acute lymphoblastic leukemia (3rd revised draft). Chin J Pediatr 2004;44:392-5
4. Wang RF, Cao WW, Cerniglia CE. PCR detection and quantitation of predominant anaerobic bacteria in human and animal fecal samples. Appl Environ Microbiol 1996;62:1242-47
5. Harmsen HJ, Wildeboer-Veloo AC, Raangs GC, Wagendorp AA, Klijn N, Bindels JG, Welling GW. Analysis of intestinal flora development in breast-fed and formula-fed infants by using molecular identification and detection methods. J Pediatr Gastroenterol Nutr 2000;30:61-7
6. Matsuki T, Watanabe K, Fujimoto J, Miyamoto Y, Takada T, Matsumoto K, Oyaizu H, Tanaka R. Development of 16srRNA-gene-targeted group-specific primers for the detection and identification of predominant bacteria in human faces. Appl Environ Microbiol 2002;68: 5445-51
7. Huijsdens XW, Linskens RK, Mak M, Meuwissen SG, Vandenbroucke-Grauls CM, Savelkoul PH. Quantification of bacteria adherent to gastrointestinal mucosa by real-time PCR. J Clin Microbiol 2002;40:4423-7
8. Requena T, Burton J, Matsuki T, Munro K, Simon MA, Tanaka R, Watanabe K, Tannock GW. Identification, detection, and enumeration of human bifidobacterium species by PCR targeting the transaldolase gene. Appl Environ Microbiol 2002;68:2420-7
9. Ott SJ, Musfeldt M, Ullmann U, Hampe J, Schreiber S. Quantification of intestinal bacterial populations by real-time PCR with a universal primer set and minor groove binder probes: a global approach to the enteric flora. J Clin Microbiol 2004;42:2566-72
10. Matsuki T, Watanabe K, Fujimoto J, Kado Y, Takada T, Matsumoto K, Tanaka R. Quantitative PCR with 16srRNA-gene-targeted species-specific primers for analysis of human intestinal bifidobacteria. Appl Environ Microbiol 2004;70:167-73
11. Guarner F, Malagelada JR. Gut flora in health and disease. Lancet 2003;361:512-9
12. Eckburg PB, Bik EM, Bernstein CN, Purdom E, Dethlefsen L, Sargent M, Gill SR, Nelson KE, Relman DA. Diversity of the human intestinal microbial flora. Science 2005;308:1635-8
13. Guarner F. Enteric flora in health and disease. Digestion 2006;73 (Suppl 1):5-12
14. Hatakka K, Savilahti E, Pönkä A, Meurman JH, Poussa T, Näse L, Saxelin M, Korpela R. Effect of long term consumption of probiotic milk on infections in children attending day care centres: double blind, randomized trial. BMJ 2001;322:1327-9
15. De-Souza DA, Greene LJ. Intestinal permeability and systemic infections in critically ill patients: effect of glutamine. Crit Care Med 2005;33: 1125-35
16. Krack A, Sharma R, Figulla HR, Anker SD. The importance of the gastrointestinal system in the pathogenesis of heart failure. Eur Heart J 2005;26:2368-74
17. Melichar B, Kohout P, Brátová M, Solichová D, Králícková P, Zadák Z. Intestinal permeability in patients with chemotherapy-induced stomatitis. J Cancer Res Clin Oncol 2001;127:314-8
18. Melichar B, Hyspler R, Dragounová E, Dvorák J, Kalábová H, Tichá A. Gastrointestinal permeability in ovarian cancer and breast cancer patients treated with paclitaxel and platinum. BMC Cancer 2007;7:155
19. Melichar B, Dvorák J, Krcmová L, Hyspler R, Urbánek L, Solichová D. Intestinal permeability and vitamin A absorption in patients with chemotherapy-induced diarrhea. Am J Clin Oncol 2008;31:580-4
20. Choi K, Lee SS, Oh SJ, Lim SY, Lim SY, Jeon WK, Oh TY, Kim JW. The effect of oral glutamine on 5-fluorouracil/leucovorin induced mucositis/stomatitis assessed by intestinal permeability test. Clin Nutr 2007;26:57-62
21. Velasco N. Gut barrier in the critically ill patient: facts and trends. Rev Med Chil 2006;134:1033-9
22. Song D, Shi B, Xue H. Confirmation and prevention of intestinal barrier dysfunction and bacterialtranslocation caused by methotrexate. Dig Dis Sci 2006;51:1549-56
23. Wang Z, Xiao G, Yao Y, Guo S, Lu K, Sheng Z. The role of bifidobacteria in gut barrier function after thermal injury in rats. J Trauma 2006;61:650-7
24. MacFie J, Reddy BS, Gatt M, Jain PK, Sowdi R, Mitchell CJ. Bacterial translocation studied in 927 patients over 13 years. Br J Surg 2006;93:87-93
25. Song D, Shi B, Xue H, Li Y, Yu B, Xu Z, Liu F, Li J. Green fluorescent protein labeling Escherichia coli TG1 confirms intestinal bacterial translocation in a rat model of chemotherapy. Curr Microbiol 2006;52:69-73
26. Xue H, Song D, Shi B, Li Y, Li J. Tracking of green fluorescent protein labeled Escherichia coli confirms bacterial translocation in blind loop rat. J Surg Res 2007;143:206-10
27. Lichtman SM. Bacterial translocation in humans. J Pediatr Gastroenterol Nutr 2001;33:1-10
28. Gatt M, Reddy BS, MacFie J. Bacterial translocation in the critically ill-evidence and methods of prevention. Aliment Pharmacol Ther 2007;25:741-57
29. Ke Z, Qiu X, Huang T. Contrast observation of HDMTX on intestinal mucosa injury and folate rescue. J Sun Yat-sen University (Medical Sciences) 2004;25(3S):41-3
30. Hooper LV, Wong MH, Thelin A, Hansson L, Falk PG, Gordon JI. Molecular analysis of commensal host-microbial relationship in the intestinal. Science 2001;291:881-4
31. Thoreux K, Senegas-Balas F, Bernard-Perrone F, Giannarelli S, Denariaz G, Bouley C, Balas D. Modulation of proliferation, second messenger levels and morphotype expression of the rat intestinal epithelial cell line IEC-6 by fermented milk. J Dairy Sci 1996;79:33-43
32. Ménard S, Candalh C, Bambou JC, Terpend K, Cerf-Bensussan N, Heyman M. Lactic acid bacteria secrete metabolites retaining anti-inflammatory properties after intestinal transport. Gut 2004;53:821-8
33. Dziarski R. Recognition of bacterial peptidogly can by the innate immune system. Cell Mol Life Sci 2003;60:1793-804
34. Liang Q, Zhang L, Duan S. Influence of intestinal dysbacteriosis on immune and hematopoietic function in mice. Chinese J Pediatr 2004;42:708-11
35. Chen Y, Wen B. A preliminary analysis on the condition of intestinal flora in leukemia patients before chemotherapy. J Clin Hematol 1998;11:216-8
36. Delaloye J, Merlani G, Petignat C, Wenger A, Zaman K, Monnerat C, Matzinger O, Beck Popovic M, Vuichard P, Ketterer N, Tarr PE. Nosocomial nontyphoidal salmonellosis after antineoplastic chemotherapy: reactivation of asymptomatic colonization. Eur J Clin Microbiol Infect Dis 2004;23:751-8
37. Baoyuan Z, Xiaohong M, Zhen L. Study on immunomodulation and antitumor activity of Bifidobacterium and its cell wall preparation in S180 tumor mice. Chin J Microecol 2001;13:82-4
38. Dongyi T, Hongchang Y. Application of bifidobiogen-livzon in the chemotherapy of the digestive system malignant tumor. China Contemp Med 2001;7:73-5
39. Hooper LV, Gordon JI. Commensal host-bacterial relationships in the gut. Science 2001;292:1115-8
40. Guarner F, Malagelada JR. Gut flora in health and disease. Lancet 2003;360:512-9